HAO — Haoxi Health Technology Income Statement
0.000.00%
Last trade - 00:00- $3.98m
- -$1.80m
- $48.52m
Annual income statement for Haoxi Health Technology, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 12.8 | 16.2 | 28.2 | 48.5 |
| Cost of Revenue | ||||
| Gross Profit | 0.606 | 0.649 | 2.06 | 2.75 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Total Operating Expenses | 12.5 | 15.9 | 27 | 46.8 |
| Operating Profit | 0.331 | 0.269 | 1.2 | 1.72 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | 0.325 | 0.26 | 1.19 | 1.74 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 0.304 | 0.245 | 0.97 | 1.29 |
| Net Income Before Extraordinary Items | ||||
| Net Income | 0.304 | 0.245 | 0.97 | 1.29 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | 0.304 | 0.245 | 0.97 | 1.29 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | 0.01 | 0.008 | 0.03 | 0.042 |
| Dividends per Share |